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Abstract
Background: Many chromosomal abnormalities are associated with Central Nervous System (CNS) malformations and 
other neurological alterations, among which seizures and epilepsy. Some of these show a peculiar epileptic and EEG 
pattern. We describe some epileptic syndromes frequently reported in chromosomal disorders.
Methods: Detailed clinical assessment, electrophysiological studies, survey of the literature.
Results: In some of these congenital syndromes the clinical presentation and EEG anomalies seems to be quite typical, 
in others the manifestations appear aspecific and no strictly linked with the chromosomal imbalance. The onset of 
seizures is often during the neonatal period of the infancy.
Conclusions: A better characterization of the electro clinical patterns associated with specific chromosomal 
aberrations could give us a valuable key in the identification of epilepsy susceptibility of some chromosomal loci, using 
the new advances in molecular cytogenetics techniques - such as fluorescent in situ hybridization (FISH), subtelomeric 
analysis and CGH (comparative genomic hybridization) microarray. However further studies are needed to understand 
the mechanism of epilepsy associated with chromosomal abnormalities.
Background
Many chromosomal abnormalities are associated with
Central Nervous System (CNS) malformations and other
neurological alterations resulting in mental retardation
(MR) and seizures that are more frequent than in general
population [1-3]. Certain chromosomal syndromes are
specifically associated with epilepsy and show a particu-
l a r  c l i n i c a l  a n d  E E G  p a t t e r n  s u c h  a s  1 p 3 6  m o n o s o m y ,
Wolf-Hirschhorn syndrome, ring 20 chromosome syn-
drome, Miller-Dieker syndrome, 18q- syndrome, and
Down syndrome. Other congenital anomalies, due to
chromosomal imbalance, differently from the above men-
tioned, have no specific patterns of seizures even if these
are frequent, for example the 14r syndrome, the
Klinefelter syndrome, the Fragile-X syndrome. Some of
these will be described successively.
Results and Discussion
For all these syndromes a better knowledge of the electro
clinical patterns associated with specific chromosomal
aberrations could give us a valuable key in the identifica-
tion of epilepsy susceptibility of some chromosomal loci
and the new advances in molecular cytogenetics tech-
niques such as fluorescent in situ hybridization (FISH),
subtelomeric analysis and CGH (comparative genomic
hybridization) microarray might allow it [4].
1p36 Monosomy
The 1p36 monosomy is a syndrome quite recently recog-
nized and characterized by mental retardation and multi-
ple congenital anomalies [5-7]. The estimated incidence
is 1/5000 to 1/10000 births [8]. The affected patients
show a peculiar phenotype consisting in microcephaly,
brachycephaly, large and late-closing anterior fontanels,
prominent forehead, straight eyebrows, short palpebral
fissures, deep-set eyes, flat nasal bridge, midface hypopla-
sia, elongated philtrum, pointed chin, hypotonic face,
low-set malformed and posterior rotated ears. Moreover
patients show brachydactyly of the fifth finger, campto-
dactyly, short feet, hearing loss mostly of the sensorineu-
ral type, various skeletal anomalies, urogenital anomalies,
congenital heart defects, cardiomyopathy, muscle hypo-
tonia, congenital hypothyroidism, different degree of cog-
nitive impairment varying from severe to moderate with
poor or absent language. Seizures are present in 50-58%
of patients. Age of seizure onset is not well defined, but
generally they start in infancy or childhood [9-11]. The
seizures are of different types including infantile spasms,
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generalized tonic-clonic seizures, complex or single par-
tial seizures, myoclonic seizures and absence seizures.
Their control with current antiepileptic drugs is quite
good. The spectrum of EEG abnormalities varies widely
and includes hypsarrhythmia, focal and multifocal spikes
and asymmetry of slow wave activity. Infantile spasms are
the most frequent type of seizures (25% of patients) and,
according to the literature, are well controlled by corti-
cotropin in the majority of the cases [7]. All kind of sei-
zures seem to improve with time and only few cases of
intractable epilepsy are reported. However the epilepsy is
highly variable among the affected patients [11]. Most
common finding at the brain magnetic resonance imag-
ing (MRI) is cortical atrophy with enlargement of the lat-
eral ventricles. Some patients show non specific posterior
white matter abnormalities or delayed myelination. In
some case a thin corpus callosum is described [9,12,13].
The causes of epilepsy in 1p36 monosomy remain
unknown. The literature suggests that the characteristic
phenotype varies with the size of the deletion being more
pronounced in larger deletions. The terminal region of
chromosome 1p is particularly gene-rich. Among the
genes present in this area, two of them might account for
epilepsy: KCNAB2 or potassium channel-β subunit gene
and GABRD or γ-aminobutyric acid A receptor δ subunit
gene. Regarding the KCNAB2, it was hypothesized that
its haplo-insufficiency could decrease the threshold for
seizures, but this hypothesis is in contrast with the obser-
vation of patients with 1p36 deletion and intractable epi-
lepsy in which no loss of KCNAB2 was present. Also the
GABRD gene maps on 1p36, but until now, no correlation
with the seizures has been demonstrated [7,14,15].
Wolf-Hirschhorn syndrome (4p- syndrome)
Wolf-Hirschhorn syndrome, a well known clinical entity,
is caused by a partial deletion of the short arm of chromo-
some 4. Its frequency is estimated as one per 50000 births
with a female predilection of 2:1 [16-18]. The syndrome is
characterized by typical cranio-facial anomalies consist-
ing of microcephaly, ocular hypertelorism, epicanthic
folds, coloboma of the iris, prominent glabella with a
"Greek warrior elmet" appearance, cleft lip and/or palate,
severe mental retardation and high prevalence of seizures
(80-90%) that include alternate hemiconvulsion, febrile
seizures, infantile spasms frequently drug resistant [19-
21]. The mean age at the seizure onset is 9 months rang-
ing from 5 to 23 months [22,23], but some patients are
reported with neonatal onset of generalized seizures
accompanied by EEG abnormalities [20,21]. Many
patients with resistant status epilepticus are also
reported. Distinctive EEG patterns are observed in about
70% of patients [21]. These patterns are essentially of two
types: one is characterized by frequent, diffuse, atypical
slow sharp element, spike and wave complexes often
occurring in long bursts activated by slow wave sleep,
with paroxysmal activity associated with typical absences.
The second type shows frequent high amplitude, fast
spikes-polyspikes and wave complexes over the posterior
third of the head, triggered by eye closure [11,24-26].
These abnormalities are even present in patients who had
not experienced seizures [20-23]. Epilepsy is generally
well-controlled with monotherapy alone and there is
good evidence of general improvement of seizures with
age [21]. At brain Magnetic Resonance Imaging (MRI)
the most frequent anomaly is corpus callosum hypoplasia
together with agenesis or hypoplasia of posterior lobe of
cerebellum. Heterotopias and dysplastic nuclear struc-
tures are also reported [4].
Angelman syndrome
Angelman syndrome can result from several mechanisms
that lead to the loss of maternally imprinted gene func-
tion. Deletions within bands 15q11-q13 of the maternally
derived chromosome is present in 70% of cases. Paternal
uniparental disomy is found in about 2-5% of cases;
remaining cases are presumed due to a mutation in a spe-
cific gene. According to literature, patients with the chro-
mosomal deletion have a more severe phenotype than
those with uniparental disomy form or those with the sin-
gle gene anomaly [19,27-29]. The clinical phenotype is
characterized by microcephaly, frontal upsweep, promi-
nent mandible, pointed chin, protruding tongue, diffuse
depigmentation. Moreover patients show severe mental
retardation, inappropriate laughter, happy disposition,
ataxic gait, jerky movements, spasticity, lack of speech
[30]. Seizures occur in 80-90% of patients and the onset is
usually between 1 and 2 years, but seizures can occur in
infants less than 1 year old or older than 3 years [31].
Atypical absences and myoclonic seizures are common as
well as non convulsive status epilepticus. Different sei-
zures types can occur in each patient. Hyperkinetic ste-
reotypes and behavioural disturbances are at risk to be
misinterpreted and considered epileptic manifestations
leading to unjustified overtreatment. Often the convul-
sions are refractory to therapy. EEG is characteristic and
demonstrates two types of epileptic discharge: burst of
high-voltage frontal dominant activity (2-3 c/s) associ-
ated with spikes and sharp waves and bursts of occipital
dominant high-voltage activity (3-4 c/s) associated with
spikes [32].
Miller-Dieker syndrome
Miller-Dieker syndrome is associated with microdele-
tions within bands 17p13.3 that includes the LIS1 gene.
The syndrome is characterized by classic lissencephaly or
type 1 lissencephaly, due to a neuronal migrational arrest
between 12 and 16 weeks of gestation resulting in a cor-
tex with four instead of six layer, profound mental retar-Sorge and Sorge Italian Journal of Pediatrics 2010, 36:36
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dation, hypotonia and spasticity, epilepsy and typical
facial features consisting of prominent forehead, bitem-
poral hollowing, short nose with upturned nares, pro-
truding upper lip, thin vermillion border of upper lip and
small jaw. Seizures, generally drug-resistant, are preco-
cious and occur very often in the first months of life in
form of partial, tonic, myoclonic or infantile spasms in
90% of cases [19,33-35]. The EEG is characterized by
high-amplitude α or β activity alternating with high
amplitude slow rhythms and simulates slow spike-wave
complexes or hypsarrhythmia. The disease follows a grim
course with only some patients surviving into adult life
[19].
18q- syndrome
Several reports suggest the association of epilepsy and
18q- syndrome [3]. This chromosomal aberration is asso-
ciated with various dysmorphisms consisting in micro-
cephaly, turricephaly, deep-set-eyes, carp shaped mouth,
broad nasal bridge, high arched or cleft palate, small
hands and feet, frequent cardiac anomalies. Patients
show moderate to severe mental retardation, aggressive
behaviour, ataxia, dysmetria, and hypotonia [29]. Dis-
turbed myelination pattern with cerebellar hypoplasia
and hydrocephalus are often present. Early epilepsy can
be a feature of the syndrome [36]. The reported seizures
are frequently autonomic epileptic seizures with cardiac
arrhythmia and apnoea simulating non epileptic syncope
[7,36,37].
Ring chromosome 20 syndrome
Ring chromosome 20 syndrome has a striking association
with epilepsy whereas in the other aberrations of the
same chromosome epilepsy is rarely reported [19]. Gen-
erally a chromosomal mosaicism is present [38]. The syn-
drome is not characterized by a particular phenotype
instead seizures occur virtually in all cases. The reported
phenotypic anomalies are represented by microcephaly,
facial dysmorphism with hypertelorism, high arched pal-
ate, long neck and trunk, thenar and hypothenar hyp-
oplasia, microgenitalism, tetraparesis, dysarthria and
sever MR, even though in many reports the intellect is
described within the normal range or mildly deficient
[19,39]. Characteristically there is a worsening of clinical
and EEG features over a long period of time and, for this
reason, an early diagnosis is often difficult [19]. Age at
onset of seizures varies from infancy to 14 years and the
seizures are characteristically resistant to treatment [40-
45]. According to the data published by Ville et al [39] the
epilepsy seems to have particular patterns that consist of
the following:
• a normal or nearly normal EEG activity with incon-
stant runs of theta waves in fronto-central areas not sig-
nificantly influenced by eye opening, level of vigilance or
intravenous injection of diazepam;
• in other instances episodes of nonconvulsive status
epilepticus with a prolonged confusion and, on the EEG,
long-lasting high-voltage slow waves with occasional
spikes usually frontal, sometimes unilateral are observed.
Spike-and-wave complexes are not a predominant fea-
ture. Otherwise there is the presence of focal seizures
associated to ictal terror and hallucinations with loss of
consciousness, oro-alimentary automatisms and hyperto-
nia with frontal onset discharges of short duration;
• pharmacoresistance;
• psychomotor delay or major behavioural disturbances
[39].
As before mentioned, the first seizure often occurs in
childhood, but most of the reported patients are adoles-
cents or adults probably because the time lag from onset
to diagnosis is usually long after many useless clinical
investigations and ineffective treatments and, in many
cases, psychiatric treatment was administered for several
years without any improvement [39]. For this reason a
cytogenetic study should be performed on all patients
having epilepsy, dysmorphic features and/or learning dis-
abilities [44]. Some cases are reported with a neonatal
onset of the epilepsy [46-50]. In these patients seizures
were generalized and the EEG was normal or showed dif-
fuse slowing. It was suggested that the severity of clinical
features may depend on the extent of chromosomal dele-
tion [45] or on the entity of lymphocyte mosaicism [38].
Down syndrome
Epilepsy occurs in 8% of individuals with Down syn-
drome (DS). Age of seizure onset is bimodal: 40% occurs
before 1 year of age and 40% occur in the third decade of
life [51]. However epilepsy in DS is less common than in
most mental retardation syndromes (19). The increased
seizure susceptibility has been attributed to inherent
structural anomalies of the brain [52-54] such as fewer
inhibitory interneurons, decreased neuronal density,
abnormal neuronal lamination, persistence of dendrites
with foetal morphology or primitive synaptic profiles
[55,56]. In patients with DS has been also documented an
altered membrane potassium permeability that increases
the voltage threshold for spike formation, reduces hyper-
polarization following spikes or increases action potential
duration [53-55]. Some authors report that seizures in DS
could be associated with medical complications such as
cardiovascular abnormalities, recurrent infections or
nutritional deficiencies [56-60]. All major seizure types
have been described in children with DS: 47% of patients
develop partial seizures, 37% infantile spasms and 21%
generalized tonic-clonic seizures [54,61]. In the younger
age the predominant type of convulsions are represented
by infantile spasms and tonic-clonic seizures with myo-
clonus [61]. Infantile spasms, particularly frequent in
male patients, are usually associated with a poor long-Sorge and Sorge Italian Journal of Pediatrics 2010, 36:36
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term prognosis (Fig. 1) [19,51,62-65]. However about half
of the children with infantile spasms achieve seizure
remission without relapse and partial restoration of
development. In the other 50% who still have seizures,
there is no difference in outcome between groups treated
with valproic acid, cotricotropin, or both [51-54]. When
seizures occur during the childhood or in the third
decade of life, generalized tonic-clonic are the most com-
mon together with partial simplex or partial complex sei-
zures, but myoclonic, atonic and absence with tonic-
seizures have been reported [19,61].
Other syndromes
In many other chromosomal disorders, seizures, not as
typical as in the above-mentioned syndromes, can be
found.
Convulsions are reported in patients affected with dele-
tion of the long arm of chromosome 1 (1q- syndrome).
In this syndrome, characterized by microcephaly, severe
MR, high-pitched cry, abnormal posturing, agenesis of
corpus callosum and diaphragmatic hernia, seizures usu-
ally begin in the first 3 years of life. Various types of sei-
zures are reported: generalized, febrile, complex partial
or not well defined [19,66-68]. All types of seizures are
often well controlled, but we do not have data about the
long-term outcome of epilepsy. The EEG patterns
reported in literature are described as multifocal or bilat-
eral central epileptiform discharge, or as centro-temporal
spikes similar to rolandic spikes [19,69].
Seizures are also reported in patients with chromosome
2 abnormalities. Regarding 2p deletion syndrome there
are isolated cases of generalized or febrile or myoclonic
seizures with onset between 6 months and 2 years of life.
The clinical phenotype of these patients is characterized
by microcephaly, severe MR and a facial resemblance to
Down syndrome [19]. The reported EEG abnormalities
consist in focal epileptic form or generalized spike-waves
discharges [70].
In patients with 2q deletion syndrome severe forms of
early onset epilepsy consisting in status epilepticus, myo-
clonic seizures, generalized seizures and drugs resistant
seizures, have been reported [3,19,71] even if convulsions
are not the prominent feature. In these patients various
patterns of EEG are reported: generalized and centro-
temporal spikes, slow background or centro-temporal-
frontal spikes and waves [71].
Seizures with fever are reported in the patients affected
with the rare short arm of chromosome 3 deletions
syndrome in which MRI abnormalities are very severe
[19].
There are no deletion or duplication syndromes associ-
ated with epilepsy on the short arm of chromosome 5
[19].
In 25% of patients affected with distal deletion of the
long arm of chromosome 6 seizures, with age of onset
ranging from 4 months to 10 years of life, are described.
Most are generalized convulsions, but infantile spasms or
complex partial seizures are also reported [72]. Elia et. al.
[73] reported 5 patients with a peculiar clinical and EEG
pattern constituted by early, focal epilepsy originating
from the occipital lobes in most cases associated with
heterotopia or neuronal migration defects, colpocephaly
and dysgenesis of the corpus callosum, thalami and brain-
stem.
Seizures onset ranging from neonatal period to 7 years
are reported in patients affected with deletion of the
long arm of chromosome 7. Febrile, generalized, myo-
clonic and combination of afebrile and febrile seizures are
described in these cases [19]. All patients show MR and
microcephaly. EEG studies are mentioned only in a few
cases and the detected anomalies consist in hypsarryth-
mia, rolandic spikes and multifocal spikes [19].
S e i z u r e s  o c c u r  i n  < 1 0 %  o f  c a s e s  o f  deletion of the
short arm of chromosome 9 [19,74]. Generally the
patients have complex partial seizures and the clinical
phenotype is characterized by short stature, MR, micro-
cephaly and severe kyphosis.
There are only isolated case reports described with epi-
lepsy on chromosome 10 and 11 [3,19,75].
Trisomy 12p is frequently associated with myoclonic
absence [76]. It is a syndrome characterized by MR, char-
acteristic cranio-facial anomalies consisting in high fore-
head, long face, succulent periorbital tissue, downslanting
palpebral fissures, flat nasal bridge, high palate, limbs
deformity such as camptodactyly of both hands and feet,
poor sucking and congenital heart defects [77].
The Pallister-Killian syndrome a rare, sporadic disor-
der caused by a mosaic supernumerary chromosome 12p
[78], has been associated with West syndrome [76].
In trisomy 13 or Patau syndrome seizures are reported
rarely even if a variety of developmental abnormalities of
the brain are present: holoprosencephaly (60-80% of Figure 1 Down Syndrome: Infantile spasms - hypsarrythmia.Sorge and Sorge Italian Journal of Pediatrics 2010, 36:36
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cases), cerebellar dysplastic changes, olfactory aplasia,
hippocampal hypoplasia and callosal agenesis. In most
cases, seizures develop during the neonatal period. Most
are multifocal clonic or photosensitive myoclonic type
(Fig. 2) [75-80]. Due to severe multiple congenital anoma-
lies the mortality is > 80% within the first month of life.
The only anomaly of chromosome 14 with a striking
association with epilepsy is the ring 14. Numerous cases
are reported, some of which familial [19,81,82]. Generally
seizures begin in infancy and various types have been
described: generalized tonic-clonic seizures, myoclonic,
minor motor seizures, complex partial seizures [82-84].
The clinical spectrum is characterized by generalized
hypotonia, ataxia, retinal and macular abnormalities,
cerebral atrophy and ventricular dilatation.
Recently reported is a syndrome due to 15q13.3
microdeletion associated with mental retardation, devel-
opmental delay and seizures [85]. In these patients, sei-
zures were of various types: myoclonic seizures, absence
seizures, tonic-clonic seizures, intractable epilepsy [85].
Affected patients show everted lips, deep-set eyes,
upslanting palpebral fissures, hypertelorism, synophris,
prominent philtrum, and hypotonic facies.
Epilepsy is an uncommon manifestation associated
with 22q11 deletion. It is present in less than 5% of the
patients [86,87].
The estimated incidence of epileptic manifestations
occurring in association with Klinefelter syndrome is 5-
17% [88]. The age of onset of seizures is within 3 months
and 3 years of age. Febrile seizures, generalized tonic-
clonic seizures, complex partial seizures and absence sei-
zures are reported [89,90]. EEG abnormalities consist of
epileptiform discharges, typically focal or multifocal. The
patients with Klinefelter syndrome and epilepsy fre-
quently have some degree of mental handicap and behav-
iour difficulties. Neuro-imaging studies failed to identify
structural basis of seizures [90].
Fragile-X syndrome (Fra-X) is the most frequent cause
of familial MR and is the second most common cause of
mental disability after DS [91]. Epilepsy in patients Fra-X
syndrome was first reported in 1969 [92]. The frequency
of epilepsy is reported from 13-14% to 41-44% [93,94].
Types of seizures in Fra-X show similarities with some
epileptic syndromes such as benign childhood epilepsy
with centro-temporal spikes, childhood epilepsy with
occipital paroxysms (Fig. 3), partial motor seizures, Lan-
dau-Kleffner syndrome, partial frontal epilepsy with
favourable evolution and status epilepticus during sleep
[91,95]. EEG anomalies similar to the benign childhood
epilepsy with centro-temporal spikes (BCECTS) are fre-
quently reported [91,93,95,96]. Incorpora et al. [91] pro-
posed that the Fra-X cases reported in her paper could be
grouped according to the pattern of seizures: with normal
EEG and no seizures, with EEG abnormalities without
seizures, with EEG abnormalities and well-controlled sei-
zures and with EEG abnormalities and severe seizures
unresponsive to treatment. Usually both epilepsy and
EEG improve with age.
Conclusions
Epileptic syndromes are frequently reported in chromo-
somal disorder. In some of these congenital syndromes
the clinical presentation and EEG anomalies seem to be
quite typical, in others the manifestations appear nonspe-
cific and not strictly linked with the chromosomal imbal-
ance. Very often the onset of seizures is during the
neonatal period or the infancy. Further studies are
Figure 2 Trisomy 13: Generalized seizures - Centro-temporal-
frontal spikes and waves. Figure 3 Fragile-X: Occipital spikes and waves.Sorge and Sorge Italian Journal of Pediatrics 2010, 36:36
http://www.ijponline.net/content/36/1/36
Page 6 of 8
needed to well delineate the clinical features of epileptic
syndromes and to understand the mechanisms of epi-
lepsy associated with chromosomal abnormalities.
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